Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic

Karen E Deffenbacher1, Javeed Iqbal, Warren Sanger

  • 1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, 68198-3135, USA.

Blood
|March 1, 2012
PubMed

Insights

Pediatric diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) are distinct entities, despite similar treatment and outcomes in children. Gene expression profiling revealed unique molecular signatures and chromosomal abnormalities in pediatric DLBCL, suggesting novel therapeutic targets.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Molecular Biology

Background:

  • Burkitt lymphoma (BL) is common in children, while diffuse large B-cell lymphoma (DLBCL) is rare.
  • Pediatric BL and DLBCL share similar treatment protocols and exhibit better outcomes in children than adults.
  • Distinct molecular profiles differentiate pediatric DLBCL from BL, despite overlapping clinical presentations.

Purpose of the Study:

  • To molecularly characterize pediatric DLBCL and compare it with adult DLBCL and pediatric BL.
  • To identify genetic alterations and pathway differences that distinguish pediatric B-cell lymphomas.
  • To explore potential novel therapeutic targets for pediatric B-cell non-Hodgkin lymphoma.

Main Methods:

  • Gene expression profiling (GEP) and miRNA expression profiling were used to cluster pediatric and adult lymphoma samples.
  • Pathway analysis of GEP data was performed to identify molecular differences.
  • Array-based comparative genomic hybridization (CGH) was employed to detect chromosomal abnormalities.

Main Results:

  • GEP and miRNA profiling clearly separated pediatric DLBCL from BL into distinct clusters.
  • Pediatric DLBCL showed a predominance of the germinal center B-cell subtype (6:1 ratio).
  • Frequent 8q24 abnormalities, including MYC alterations, were observed in pediatric DLBCL (31% rearrangement, 50% gain/amplification).
  • MYC rearrangement was highly prevalent in BL (96%).
  • CGH analysis revealed shared and unique chromosomal abnormalities between pediatric and adult DLBCL, suggesting distinct pathogenetic mechanisms.

Conclusions:

  • Pediatric DLBCL and BL are molecularly distinct entities.
  • Pediatric DLBCL harbors unique genetic alterations, including MYC pathway involvement and specific chromosomal abnormalities.
  • These findings highlight age-related pathogenetic differences and suggest potential novel therapeutic targets for pediatric B-cell lymphomas.

Related Concept Videos

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...